Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Ocular Drug Delivery Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Ocular Drug Delivery Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Ocular Insert
      • 1.3.3 Iontophoresis
      • 1.3.4 Intraocular Implants
      • 1.3.5 In Situ Gel & Punctal Plugs
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Ocular Drug Delivery Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Ambulatory Surgical Centers
      • 1.4.4 Ophthalmic Clinics
      • 1.4.5 Homecare Settings
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Ocular Drug Delivery Market Size
      • 2.1.1 Global Ocular Drug Delivery Revenue 2014-2025
      • 2.1.2 Global Ocular Drug Delivery Sales 2014-2025
    • 2.2 Ocular Drug Delivery Growth Rate by Regions
      • 2.2.1 Global Ocular Drug Delivery Sales by Regions 2014-2019
      • 2.2.2 Global Ocular Drug Delivery Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Ocular Drug Delivery Sales by Manufacturers
      • 3.1.1 Ocular Drug Delivery Sales by Manufacturers 2014-2019
      • 3.1.2 Ocular Drug Delivery Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Ocular Drug Delivery Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ocular Drug Delivery Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Ocular Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.3 Ocular Drug Delivery Price by Manufacturers
    • 3.4 Key Manufacturers Ocular Drug Delivery Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Ocular Drug Delivery Market
    • 3.6 Key Manufacturers Ocular Drug Delivery Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Ocular Insert Sales and Revenue (2014-2019)
      • 4.1.2 Iontophoresis Sales and Revenue (2014-2019)
      • 4.1.3 Intraocular Implants Sales and Revenue (2014-2019)
      • 4.1.4 In Situ Gel & Punctal Plugs Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Ocular Drug Delivery Sales Market Share by Type
    • 4.3 Global Ocular Drug Delivery Revenue Market Share by Type
    • 4.4 Ocular Drug Delivery Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Ocular Drug Delivery Sales by Application

    6 United States

    • 6.1 United States Ocular Drug Delivery Breakdown Data by Company
    • 6.2 United States Ocular Drug Delivery Breakdown Data by Type
    • 6.3 United States Ocular Drug Delivery Breakdown Data by Application

    7 European Union

    • 7.1 European Union Ocular Drug Delivery Breakdown Data by Company
    • 7.2 European Union Ocular Drug Delivery Breakdown Data by Type
    • 7.3 European Union Ocular Drug Delivery Breakdown Data by Application

    8 China

    • 8.1 China Ocular Drug Delivery Breakdown Data by Company
    • 8.2 China Ocular Drug Delivery Breakdown Data by Type
    • 8.3 China Ocular Drug Delivery Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Ocular Drug Delivery Breakdown Data by Company
    • 9.2 Rest of World Ocular Drug Delivery Breakdown Data by Type
    • 9.3 Rest of World Ocular Drug Delivery Breakdown Data by Application
    • 9.4 Rest of World Ocular Drug Delivery Breakdown Data by Countries
      • 9.4.1 Rest of World Ocular Drug Delivery Sales by Countries
      • 9.4.2 Rest of World Ocular Drug Delivery Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 OCULAR THERAPEUTIX, INC
      • 10.1.1 OCULAR THERAPEUTIX, INC Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.1.4 Ocular Drug Delivery Product Introduction
      • 10.1.5 OCULAR THERAPEUTIX, INC Recent Development
    • 10.2 Alimera Sciences
      • 10.2.1 Alimera Sciences Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.2.4 Ocular Drug Delivery Product Introduction
      • 10.2.5 Alimera Sciences Recent Development
    • 10.3 Allergan, Plc
      • 10.3.1 Allergan, Plc Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.3.4 Ocular Drug Delivery Product Introduction
      • 10.3.5 Allergan, Plc Recent Development
    • 10.4 EyeGate Pharma
      • 10.4.1 EyeGate Pharma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.4.4 Ocular Drug Delivery Product Introduction
      • 10.4.5 EyeGate Pharma Recent Development
    • 10.5 Valeant Pharmaceuticals International, Inc
      • 10.5.1 Valeant Pharmaceuticals International, Inc Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.5.4 Ocular Drug Delivery Product Introduction
      • 10.5.5 Valeant Pharmaceuticals International, Inc Recent Development
    • 10.6 Envisia Therapeutics
      • 10.6.1 Envisia Therapeutics Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.6.4 Ocular Drug Delivery Product Introduction
      • 10.6.5 Envisia Therapeutics Recent Development
    • 10.7 Clearside Biomedical
      • 10.7.1 Clearside Biomedical Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.7.4 Ocular Drug Delivery Product Introduction
      • 10.7.5 Clearside Biomedical Recent Development
    • 10.8 Graybug Vision Inc
      • 10.8.1 Graybug Vision Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.8.4 Ocular Drug Delivery Product Introduction
      • 10.8.5 Graybug Vision Inc Recent Development
    • 10.9 Taiwan Liposome Company
      • 10.9.1 Taiwan Liposome Company Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.9.4 Ocular Drug Delivery Product Introduction
      • 10.9.5 Taiwan Liposome Company Recent Development
    • 10.10 Santen Pharmaceutical Co., Ltd
      • 10.10.1 Santen Pharmaceutical Co., Ltd Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Ocular Drug Delivery
      • 10.10.4 Ocular Drug Delivery Product Introduction
      • 10.10.5 Santen Pharmaceutical Co., Ltd Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Ocular Drug Delivery Sales Channels
      • 11.2.2 Ocular Drug Delivery Distributors
    • 11.3 Ocular Drug Delivery Customers

    12 Market Forecast

    • 12.1 Global Ocular Drug Delivery Sales and Revenue Forecast 2019-2025
    • 12.2 Global Ocular Drug Delivery Sales Forecast by Type
    • 12.3 Global Ocular Drug Delivery Sales Forecast by Application
    • 12.4 Ocular Drug Delivery Forecast by Regions
      • 12.4.1 Global Ocular Drug Delivery Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Ocular Drug Delivery Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Ocular Drug Delivery is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ocular Drug Delivery.

      This report studies the global market size of Ocular Drug Delivery, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Ocular Drug Delivery sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      OCULAR THERAPEUTIX, INC
      Alimera Sciences
      Allergan, Plc
      EyeGate Pharma
      Valeant Pharmaceuticals International, Inc
      Envisia Therapeutics
      Clearside Biomedical
      Graybug Vision Inc
      Taiwan Liposome Company
      Santen Pharmaceutical Co., Ltd

      Market Segment by Product Type
      Ocular Insert
      Iontophoresis
      Intraocular Implants
      In Situ Gel & Punctal Plugs
      Others

      Market Segment by Application
      Hospitals
      Ambulatory Surgical Centers
      Ophthalmic Clinics
      Homecare Settings

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Ocular Drug Delivery status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Ocular Drug Delivery manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Ocular Drug Delivery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now